Ryme Medical Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.3M

  • Investors
  • 4

Ryme Medical General Information

Description

Developer of catheter-based therapies designed to treat patients with chronic bronchitis and emphysema. The company focuses on addressing chronic obstructive pulmonary disease by targeting the sympathetic nervous system, taking away its impact, and alleviating the suffering of those who struggle to breathe, enabling patients to have better treatment and breathe without much struggle.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2495 Hospital Drive
  • Suite 300
  • Mountain View, CA 94040
  • United States
Primary Industry
Drug Discovery
Corporate Office
  • 2495 Hospital Drive
  • Suite 300
  • Mountain View, CA 94040
  • United States

Ryme Medical Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ryme Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 19-Aug-2024 $6.3M Completed Startup
2. Early Stage VC (Series A) 03-Feb-2023 Completed Startup
1. Seed Round $5.67M $5.67M Completed Startup
To view Ryme Medical’s complete valuation and funding history, request access »

Ryme Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Ryme Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ryme Medical Patents

Ryme Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260345218-A1 Cryotherapeutic devices, systems, and methods for targeted lung neuromodulation Pending 04-Mar-2025
WO-2026187949-A1 Cryotherapeutic devices, systems, and methods for targeted lung neuromodulation Pending 04-Mar-2025
AU-2023365504-A1 Cryotherapeutic systems and methods for targeted lung neuromodulation therapies Pending 20-Oct-2022
EP-4604861-A1 Cryotherapeutic systems and methods for targeted lung neuromodulation therapies Pending 20-Oct-2022
US-20240130775-A1 Cryotherapeutic systems and methods for targeted lung neuromodulation therapies Pending 20-Oct-2022 A61B18/02
To view Ryme Medical’s complete patent history, request access »

Ryme Medical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Epidarex Capital Venture Capital Minority
Seroba Life Sciences Venture Capital Minority
Fogarty Innovation Accelerator/Incubator Minority
Santé Ventures Venture Capital Minority
To view Ryme Medical’s complete investors history, request access »

Ryme Medical FAQs

  • When was Ryme Medical founded?

    Ryme Medical was founded in 2021.

  • Where is Ryme Medical headquartered?

    Ryme Medical is headquartered in Mountain View, CA.

  • What industry is Ryme Medical in?

    Ryme Medical’s primary industry is Drug Discovery.

  • Is Ryme Medical a private or public company?

    Ryme Medical is a Private company.

  • What is the current valuation of Ryme Medical?

    The current valuation of Ryme Medical is .

  • What is Ryme Medical’s current revenue?

    The current revenue for Ryme Medical is .

  • How much funding has Ryme Medical raised over time?

    Ryme Medical has raised $22M.

  • Who are Ryme Medical’s investors?

    Epidarex Capital, Seroba Life Sciences, Fogarty Innovation, and Santé Ventures have invested in Ryme Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process